000 | 01032 a2200289 4500 | ||
---|---|---|---|
005 | 20250518042104.0 | ||
264 | 0 | _c20200214 | |
008 | 202002s 0 0 eng d | ||
022 | _a1365-2036 | ||
024 | 7 |
_a10.1111/apt.15285 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOlaisen, Maya | |
245 | 0 | 0 |
_aEditorial: mesalamine and mucosal microbiome in quiescent ulcerative colitis-what can we learn? Authors' reply. _h[electronic resource] |
260 |
_bAlimentary pharmacology & therapeutics _c06 2019 |
||
300 |
_a1532 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAminosalicylic Acid |
650 | 0 | 4 | _aAnti-Inflammatory Agents, Non-Steroidal |
650 | 0 | 4 | _aColitis, Ulcerative |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMesalamine |
650 | 0 | 4 | _aMicrobiota |
700 | 1 | _aFossmark, Reidar | |
773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 49 _gno. 12 _gp. 1532 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.15285 _zAvailable from publisher's website |
999 |
_c29735395 _d29735395 |